<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02915614</url>
  </required_header>
  <id_info>
    <org_study_id>AAT 2016</org_study_id>
    <nct_id>NCT02915614</nct_id>
  </id_info>
  <brief_title>Effects of Pulmonary Rehabilitation on Skeletal Muscle in COPD Patients</brief_title>
  <official_title>Effects of Pulmonary Rehabilitation on Skeletal Muscle Morphology and Metabolism in PiMM vs. PiZZ COPD Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinikum Berchtesgadener Land der Schön-Kliniken</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CSL Behring</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Klinikum Berchtesgadener Land der Schön-Kliniken</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In a former study, the investigator observed significant differences in the response to
      pulmonary rehabilitation between COPD patients with the &quot;normal&quot; genetic variant of alpha-1
      antitrypsin (PiMM) and those with a homozygous deficient variant (PiZZ) (Jarosch et al.,
      2016, DOI: 10.1159/000449509). PiZZ COPD patients showed less improvement in exercise
      capacity compared to PiMM patients. This latter finding was mirrored by an increase of
      oxidative myofiber type I proportion - that is important for aerobic exercises in daily life
      - in PiMM but not PiZZ patients.

      Based on this finding of impaired skeletal muscle adaptation, the aim of this study is to
      compare the effects of pulmonary rehabilitation including exercise training on a) specific
      enzymes of energy metabolism reflecting the oxidative capacity of the skeletal muscle and b)
      the analogue gene expression of these oxidative enzymes in a cohort of PiMM and PiZZ COPD
      patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 2, 2017</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endurance time</measure>
    <time_frame>3 weeks</time_frame>
    <description>Will be measured during a constant work rate cycling test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Myofibre type I Distribution</measure>
    <time_frame>3 weeks</time_frame>
    <description>Skeletal muscle sample will be taken from the M.vastus lateralis via Bergström muscle biopsy needle</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Capillary to fibre ratio</measure>
    <time_frame>3 weeks</time_frame>
    <description>Skeletal muscle sample will be taken from the M.vastus lateralis via Bergström muscle biopsy needle</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>muscle strength</measure>
    <time_frame>3 weeks</time_frame>
    <description>strength test in the right knee Extensor and flexor</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>PiMM patients</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>COPD patients with the Alpha-1 antitrypsin genetic variant &quot;PiMM&quot; (Smoking-related COPD)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PiZZ patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>COPD patients with alpha-1 antitrypsin deficiency (genotype PiZZ)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pulmonary rehabilitation</intervention_name>
    <description>3-weeks of inpatient pulmonary Rehabilitation including exercise Training (daily endurance and strength Training)</description>
    <arm_group_label>PiMM patients</arm_group_label>
    <arm_group_label>PiZZ patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic obstructive pulmonary disease (GOLD stage III-IV)

          -  phenotype PiMM or PiZZ

          -  written informed consent

        Exclusion Criteria:

          -  any comorbidities that prevent patients from participating in an exercise Training
             program

          -  necessity of anticoagulant therapy

          -  other genetic variants of alpha-1 antitrypsin than PiMM or PiZZ
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Klaus Kenn, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of respiratory medicine, Schoen Klinik Berchtesgadener Land</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Inga Jarosch</last_name>
    <phone>+49865293</phone>
    <phone_ext>1730</phone_ext>
    <email>ijarosch@schoen-kliniken.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Schoen Klinik Berchtesgadener Land</name>
      <address>
        <city>Schönau Am Königssee</city>
        <zip>83471</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inga Jarosch</last_name>
      <phone>0049-8652-931730</phone>
      <email>ijarosch@schoen-kliniken.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2016</study_first_submitted>
  <study_first_submitted_qc>September 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 27, 2016</study_first_posted>
  <last_update_submitted>March 13, 2018</last_update_submitted>
  <last_update_submitted_qc>March 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Klinikum Berchtesgadener Land der Schön-Kliniken</investigator_affiliation>
    <investigator_full_name>Klaus Kenn</investigator_full_name>
    <investigator_title>Head physician, Department of Respiratory Medicine</investigator_title>
  </responsible_party>
  <keyword>alpha-1 antitrypsin deficiency</keyword>
  <keyword>pulmonary rehabilitation</keyword>
  <keyword>exercise training</keyword>
  <keyword>skeletal muscle biopsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alpha 1-Antitrypsin</mesh_term>
    <mesh_term>Protein C Inhibitor</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

